In human breast cancer, several works refer to ERBB2 mRNA overexpression in a low percentage of samples [39], [70], and some recent works have also observed low levels of ERBB2 mRNA, suggesting the occurrence of ERBB2 mRNA underexpression in HBC [39], [40]. This evidence concerns the gene ERBB2 and breast cancer.